Close Menu

NEW YORK (360Dx) – Ahead of Danaher's presentation at the 37th annual JP Morgan Healthcare Conference in San Francisco this week, the Washington-based conglomerate said that its fourth quarter core revenue growth is expected to be above its previous guidance of about 4 percent growth, while adjusted EPS would be at or near the previous estimate of between $1.25 to $1.28. Growth was driven by its life science and diagnostics businesses, the firm said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.